A novel oral combination drug therapy evaluated at Huntsman Cancer Institute could treat and prevent melanoma spreading to the brain. Brain metastasis is the main cause of death from melanoma.
The Cardiovascular Research Foundation (CRF) is pleased to announce that registration is now open for TCT 2025 (Transcatheter Cardiovascular Therapeutics庐), the world鈥檚 premier educational symposium in interventional cardiovascular medicine. TCT 2025 will take place October 25-28, 2025, at the Moscone Center in San Francisco, California.
Researchers at The University of Texas at El Paso have successfully tested a faster, more sensitive and reliable way to diagnose Chagas disease, a debilitating parasitic illness that affects approximately 6 million people worldwide. The results of the new study were recently published in the International Journal of Molecular Sciences.
Hearing the word 鈥渓eukemia鈥� can be alarming in any context. Hearing it in the context of your child鈥檚 health might feel terrifying, unfair, and even hopeless.聽But according to leading pediatric leukemia experts, families grappling with the news of a diagnosis have reason to feel .Today, for a great majority of pediatric leukemia cases, a new diagnosis doesn鈥檛 mean what it meant 30, 20, or even 10 years ago.
A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most likely to benefit from partial gland cryoablation, a minimally invasive procedure that treats localized prostate tumors.
Roswell Park Named One of Only 37 Optum Cancer Centers of Excellence for Adult and Pediatric Patients
New patient webinar from NCCN Foundation addresses: 1. What is the Purpose of Cancer Clinical Trials? 2. What is the Role of Clinical Trials in Cancer Treatment, Including Risks and Benefits? 3. How do you Access Cancer Clinical Trials?
Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy. The study was published in Cancer Discovery by researchers from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine鈥檚 Abramson Cancer Center.
Children's Hospital Los Angeles developed work-study jobs for college students interested in medical careers
A national multi-site clinical trial, co-led by researchers at the UNC School of Medicine, has found that therapeutic hypothermia may be harming preterm infants recovering from a specific type of brain injury.
A study, published in Cancer Cell, shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States Food and Drug Administration to treat gastrointestinal stromal tumors with a PDGFRA exon 18 mutation as well advanced systemic mastocytosis and indolent systemic mastocytosis.
A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a decades-old medication used by most hospitals in the U.S. and could hold significant advantages for some patients, a study led by a UT Southwestern Medical Center researcher shows. The findings, published in JAMA Network Open, could encourage more hospitals to use the newer drug, tenecteplase.
A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR Memorial Hermann.
Like a football team disrupting the opponent鈥檚 play, Michelle Ozbun, PhD, and Jason McConville, PhD, at the UNM Comprehensive Cancer Center are designing a gel to prevent cancers caused by human papillomaviruses (HPVs). No other antiviral treatments for HPV diseases are available.
University of Maryland School of Medicine (UMSOM) researchers helped conduct an important new global health study that found a vaccine that protects against five strains of meningitis prevalent in sub-Saharan Africa is safe and effective for use in young children beginning at 9 months of age.
Join Advocate Health and Wake Forest University School of Medicine to discuss the significance of cardiology research and its life-changing impact on patient care.
鈥淏eing diagnosed with prostate cancer is not a death knell,鈥� said Montgomery, senior author of a literature and trial review that appeared in JAMA today. Montgomery is the clinical director of Genitourinary Oncology at Fred Hutch Cancer Center and University of Washington Medical Center, and a professor of medicine and urology at the UW School of Medicine.
Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 海角社区 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right